Publicaciones en las que colabora con AITOR DOMINGO REMENTERIA RUIZ (48)

2024

  1. Candida albicans increases the aerobic glycolysis and activates MAPK–dependent inflammatory response of liver sinusoidal endothelial cells

    Microbes and Infection

  2. Identification of the Most Immunoreactive Antigens of Candida auris to IgGs from Systemic Infections in Mice

    Journal of Proteome Research

2023

  1. Dot Immunobinding Assay for the Rapid Serodetection of Scedosporium/Lomentospora in Cystic Fibrosis Patients

    Journal of Fungi, Vol. 9, Núm. 2

  2. Microbiota and fungal-bacterial interactions in the cystic fibrosis lung

    FEMS Microbiology Reviews, Vol. 47, Núm. 3

2022

  1. Flexible multiplex PCR to detect SARS-CoV-2, coronavirus OC43 and influenza A virus in nasopharyngeal swab samples

    Journal of Applied Microbiology, Vol. 133, Núm. 6, pp. 3534-3545

2021

  1. Fungal diversity and composition of the continental solar saltern in añana salt valley (Spain)

    Journal of Fungi, Vol. 7, Núm. 12

  2. The host immune response to Scedosporium/Lomentospora

    Journal of Fungi, Vol. 7, Núm. 2, pp. 1-20

2020

  1. ELISA Test for the Serological Detection of Scedosporium/Lomentospora in Cystic Fibrosis Patients

    Frontiers in Cellular and Infection Microbiology, Vol. 10

  2. Identification of Mucor circinelloides antigens recognized by sera from immunocompromised infected mice

    Revista Iberoamericana de Micologia, Vol. 37, Núm. 3-4, pp. 81-86

  3. Melanin and pyomelanin in Aspergillus fumigatus: from its genetics to host interaction

    International microbiology: official journal of the Spanish Society for Microbiology, Vol. 23, Núm. 1, pp. 55-63

  4. The monoclonal antibody Ca37, developed against Candida albicans alcohol dehydrogenase, inhibits the yeast in vitro and in vivo

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Study of humoral responses against Lomentospora/scedosporium spp. And aspergillus fumigatus to identify L. prolificans antigens of interest for diagnosis and treatment

    Vaccines, Vol. 7, Núm. 4

2018

  1. Microglial immune response is impaired against the neurotropic fungus Lomentospora prolificans

    Cellular Microbiology, Vol. 20, Núm. 8

  2. Mikroorganismoek minbizia eragin dezakete?

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 34, pp. 9-28

  3. Pathobiology of Lomentospora prolificans: could this species serve as a model of primary antifungal resistance?

    International Journal of Antimicrobial Agents, Vol. 51, Núm. 1, pp. 10-15

  4. Proteomics as a Tool to Identify New Targets Against Aspergillus and Scedosporium in the Context of Cystic Fibrosis

    Mycopathologia, Vol. 183, Núm. 1, pp. 273-289

  5. Scedosporium and Lomentospora: An updated overview of underrated opportunists

    Medical Mycology, Vol. 56, pp. S102-S125

2017

  1. Molecular and cellular responses of the pathogenic fungus Lomentospora prolificans to the antifungal drug voriconazole

    PLoS ONE, Vol. 12, Núm. 3

  2. The role of osmolarity adjusting agents in the regulation of encapsulated cell behavior to provide a safer and more predictable delivery of therapeutics

    Drug Delivery, Vol. 24, Núm. 1, pp. 1654

2016

  1. Cyclophilin and enolase are the most prevalent conidial antigens of Lomentospora prolificans recognized by healthy human salivary IgA and cross-react with Aspergillus fumigatus

    Proteomics - Clinical Applications, Vol. 10, Núm. 9-10, pp. 1058-1067